Renal Tubular HIF-2α Expression Requires VHL Inactivation and Causes Fibrosis and Cysts

被引:74
作者
Schietke, Ruth E. [1 ]
Hackenbeck, Thomas [1 ]
Tran, Maxine [3 ]
Guenther, Regina [1 ]
Klanke, Bernd [2 ]
Warnecke, Christina L. [2 ]
Knaup, Karl X. [2 ]
Shukla, Deepa [3 ]
Rosenberger, Christian [4 ]
Koesters, Robert [5 ]
Bachmann, Sebastian [6 ]
Betz, Peter [7 ]
Schley, Gunnar [2 ]
Schoedel, Johannes [2 ]
Willam, Carsten [2 ]
Winkler, Thomas [8 ]
Amann, Kerstin [9 ]
Eckardt, Kai-Uwe [2 ]
Maxwell, Patrick [3 ]
Wiesener, Michael S. [1 ,2 ]
机构
[1] Univ Erlangen Nurnberg, Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany
[3] UCL, Rayne Inst, London, England
[4] Univ Med Berlin, Dept Nephrol, Charite, Berlin, Germany
[5] Univ Paris 06, INSERM, Hop Tenon, UMR S 702, Paris, France
[6] Univ Med Berlin, Charite, Inst Vegetat Anat, Berlin, Germany
[7] Univ Erlangen Nurnberg, Dept Forens Med, D-91054 Erlangen, Germany
[8] Univ Erlangen Nurnberg, Dept Genet, D-91054 Erlangen, Germany
[9] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany
关键词
VON-HIPPEL-LINDAU; HYPOXIA-INDUCIBLE FACTOR; GENE-EXPRESSION; E-CADHERIN; IN-VIVO; KIDNEY; ACTIVATION; HIF; INDUCTION; INJURY;
D O I
10.1371/journal.pone.0031034
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Hypoxia-inducible transcription Factor (HIF) represents an important adaptive mechanism under hypoxia, whereas sustained activation may also have deleterious effects. HIF activity is determined by the oxygen regulated alpha-subunits HIF-1 alpha or HIF-2 alpha. Both are regulated by oxygen dependent degradation, which is controlled by the tumor suppressor "von Hippel-Lindau" (VHL), the gatekeeper of renal tubular growth control. HIF appears to play a particular role for the kidney, where renal EPO production, organ preservation from ischemia-reperfusion injury and renal tumorigenesis are prominent examples. Whereas HIF-1 alpha is inducible in physiological renal mouse, rat and human tubular epithelia, HIF-2 alpha is never detected in these cells, in any species. In contrast, distinct early lesions of biallelic VHL inactivation in kidneys of the hereditary VHL syndrome show strong HIF-2 alpha expression. Furthermore, knockout of VHL in the mouse tubular apparatus enables HIF-2 alpha expression. Continuous transgenic expression of HIF-2 alpha by the Ksp-Cadherin promotor leads to renal fibrosis and insufficiency, next to multiple renal cysts. In conclusion, VHL appears to specifically repress HIF-2 alpha in renal epithelia. Unphysiological expression of HIF-2 alpha in tubular epithelia has deleterious effects. Our data are compatible with dedifferentiation of renal epithelial cells by sustained HIF-2 alpha expression. However, HIF-2 alpha overexpression alone is insufficient to induce tumors. Thus, our data bear implications for renal tumorigenesis, epithelial differentiation and renal repair mechanisms.
引用
收藏
页数:12
相关论文
共 52 条
[1]   Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice [J].
Asada, Nariaki ;
Takase, Masayuki ;
Nakamura, Jin ;
Oguchi, Akiko ;
Asada, Misako ;
Suzuki, Norio ;
Yamarnura, Ken-ichi ;
Nagoshi, Narihito ;
Shibata, Shinsuke ;
Rao, Tata Nageswara ;
Fehling, Hans Joerg ;
Fukatsu, Atsushi ;
Minegishi, Naoko ;
Kita, Toru ;
Kimura, Takeshi ;
Okano, Hideyuki ;
Yamamoto, Masayuki ;
Yanagita, Motoko .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (10) :3981-3990
[2]   Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model [J].
Bernhardt, W. M. ;
Gottmann, U. ;
Doyon, F. ;
Buchholz, B. ;
Campean, V. ;
Schoedel, J. ;
Reisenbuechler, A. ;
Klaus, S. ;
Arend, M. ;
Flippin, L. ;
Willam, C. ;
Wiesener, M. S. ;
Yard, B. ;
Warnecke, C. ;
Eckardt, K. -U. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (50) :21276-21281
[3]   Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure [J].
Bernhardt, Wanja M. ;
Campean, Valentina ;
Kany, Sarah ;
Juergensen, Jan-Steffen ;
Weidemann, Alexander ;
Warnecke, Christina ;
Arend, Michael ;
Klaus, Stephen ;
Gunzler, Volkmar ;
Amann, Kerstin ;
Willam, Carsten ;
Wiesener, Michael S. ;
Eckardt, Kai-Uwe .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (07) :1970-1978
[4]   Involvement of hypoxia-inducible transcription factors in polycystic kidney disease [J].
Bernhardt, Wanja Michael ;
Wiesener, Michael Sean ;
Weidemann, Alexander ;
Schmitt, Roland ;
Weichert, Wilko ;
Lechler, Philipp ;
Campean, Valentina ;
Ong, Albert Chee Meng ;
Willam, Carsten ;
Gretz, Norbert ;
Eckardt, Kai-Uwe .
AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (03) :830-842
[5]  
Eckardt Kai-Uwe, 2005, Kidney Int Suppl, pS46
[6]   Regulation of E-cadherin expression by VHL and hypoxia-inducible factor [J].
Esteban, MA ;
Tran, MGB ;
Harten, SK ;
Hill, P ;
Castellanos, MC ;
Chandra, A ;
Raval, R ;
O'Brien, TS ;
Maxwell, PH .
CANCER RESEARCH, 2006, 66 (07) :3567-3575
[7]   Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics [J].
Fine, Leon G. ;
Norman, Jill T. .
KIDNEY INTERNATIONAL, 2008, 74 (07) :867-872
[8]   Human cancers converge at the HIF-2α oncogenic axis [J].
Franovic, Aleksandra ;
Holterman, Chet E. ;
Payette, Josianne ;
Lee, Stephen .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (50) :21306-21311
[9]   pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation [J].
Frew, Ian J. ;
Thoma, Claudio R. ;
Georgiev, Strahil ;
Minola, Andrea ;
Hitz, Manuela ;
Montani, Matteo ;
Moch, Holger ;
Krek, Wilhelm .
EMBO JOURNAL, 2008, 27 (12) :1747-1757
[10]   Generation of a Mouse Model of Von Hippel-Lindau Kidney Disease Leading to Renal Cancers by Expression of a Constitutively Active Mutant of HIF1α [J].
Fu, Leiping ;
Wang, Gang ;
Shevchuk, Maria M. ;
Nanus, David M. ;
Gudas, Lorraine J. .
CANCER RESEARCH, 2011, 71 (21) :6848-6856